What is the appropriate management of a patient with severe hyperosmolar hyperglycemia presenting with facial palsy?

Management of Severe Hyperosmolar Hyperglycemia with Facial Palsy

A patient presenting with severe hyperosmolar hyperglycemia and facial palsy requires immediate ICU-level care with aggressive fluid resuscitation as the primary intervention, followed by careful insulin therapy once osmolality stops declining with fluids alone, while simultaneously investigating whether the facial palsy is a reversible metabolic complication or represents a separate neurological process.

Immediate Assessment and Diagnosis

Confirm Hyperosmolar Hyperglycemic State (HHS)

Diagnostic criteria based on current guidelines 1:

• Glucose ≥30 mmol/L (540 mg/dL)
• Serum osmolality ≥320 mOsm/kg [calculated as: (2×Na+) + glucose + urea]
• Absence of significant ketosis (ketones ≤3.0 mmol/L)
• Minimal acidosis (pH >7.3, bicarbonate ≥15 mmol/L)
• Altered mental status or neurological findings (which may include the facial palsy)

Evaluate the Facial Palsy

The facial palsy in this context requires urgent differentiation 2:

Central vs. Peripheral Pattern:

• Central facial palsy (forehead sparing) suggests intracranial pathology and may be a direct metabolic complication of severe hyperglycemia
• Peripheral facial palsy (complete hemifacial weakness) suggests Bell's palsy or other peripheral nerve pathology

Critical distinction: A case report documents reversible central facial paralysis occurring during diabetic ketoacidosis that resolved completely within 5 days after metabolic correction 2. This suggests that severe metabolic derangement from hyperglycemia can directly cause central facial paralysis through mechanisms not yet fully understood.

Initial Management (0-60 Minutes)

1. Fluid Resuscitation - PRIMARY INTERVENTION

This is the cornerstone of HHS management and takes precedence over insulin 1, 3:

• Start 0.9% sodium chloride immediately
• Rate: 15-20 mL/kg/h or 1-1.5 L/h for the first hour 4
• Goal: Replace approximately 50% of estimated fluid loss within first 12 hours 1
• Estimated fluid deficit is typically 100-220 mL/kg 1
• Exercise caution in elderly patients due to risk of fluid overload 1

2. Laboratory Monitoring

Obtain immediately:

• Serum osmolality (calculated and measured)
• Complete metabolic panel with sodium, potassium
• Blood glucose
• Arterial or venous blood gas
• Serum ketones (to rule out mixed DKA/HHS)
• Creatinine and renal function

3. Neurological Assessment

Urgent brain imaging (MRI preferred over CT) is indicated to exclude:

• Acute stroke (given altered mental status and facial palsy)
• Intracranial hemorrhage
• Other structural lesions

The case report showed normal MRI findings in metabolic-induced central facial palsy 2, but imaging is essential to rule out life-threatening structural causes.

Ongoing Management (1-6 Hours)

Insulin Therapy - DELAYED Until Appropriate

Critical guideline point: Do NOT start insulin immediately 1, 3:

• Start fixed-rate IV insulin (FRIII) ONLY when osmolality stops declining with fluid replacement alone
• Exception: If significant ketonaemia is present, start insulin simultaneously with fluids
• Dose: 0.05 units/kg/h (JBDS guideline) 1
• Increase by 1 unit/h if inadequate response
• Target glucose reduction: Maintain 10-15 mmol/L (180-270 mg/dL) in first 24 hours 1

Rationale: Premature insulin administration can cause rapid osmolality shifts and increase risk of cerebral edema 4.

Osmolality Management

Target rate of osmolality decline: 3-8 mOsm/kg/h 1:

• More gradual than the <3 mOsm/kg/h recommended by some guidelines 5
• Prevents osmotic demyelination syndrome and cerebral edema 4, 1
• Monitor osmolality every 1-2 hours initially

Electrolyte Replacement

Potassium management 1:

• If K+ <3.5 mmol/L: Give 40 mmol/h until >3.5 mmol/L before starting insulin
• If K+ 3.5-5.5 mmol/L: Add 40 mmol/L to each liter of fluid
• If K+ >5.5 mmol/L: Withhold potassium but recheck in 2 hours

Management of Facial Palsy Component

If Central Pattern (Forehead Sparing)

Strongly consider this as a reversible metabolic complication 2:

• Continue aggressive metabolic correction
• Repeat neuroimaging if no improvement within 48-72 hours
• The facial palsy may completely resolve with metabolic stabilization (typically within 5 days) 2
• Do NOT initiate corticosteroids - they will worsen hyperglycemia

If Peripheral Pattern (Bell's Palsy)

Corticosteroids are contraindicated in acute HHS 6:

• Standard Bell's palsy treatment includes corticosteroids within 72 hours 7
• However, in patients with severe hyperglycemia, steroids significantly worsen glucose control (mean increase ~10 mg/dL) 6
• Risk of hyperosmolar hyperglycemic state increases (NNH = 80) 6
• Defer steroid treatment until HHS is fully resolved (osmolality <300 mOsm/kg, glucose stable)
• Provide supportive eye care: artificial tears, eye ointment, nighttime taping 7

Monitoring Phase (6-24 Hours)

Clinical Targets at 24 Hours 1

• Osmolality declining steadily (3-8 mOsm/kg/h)
• Blood glucose 10-15 mmol/L (180-270 mg/dL)
• Urine output ≥0.5 mL/kg/h (indicates adequate rehydration)
• Improved mental status
• Hypovolaemia corrected

Glucose Management

• Once glucose <14 mmol/L (252 mg/dL): Start 5% or 10% dextrose infusion 1
• Continue insulin to maintain glucose 10-15 mmol/L
• Prevents hypoglycemia while continuing to correct hyperosmolality

Facial Palsy Reassessment

• Document progression or improvement
• If central pattern improving: Supports metabolic etiology
• If worsening or new neurological signs: Repeat imaging urgently

Critical Complications to Prevent

Cerebral Edema 4

• Mortality 70% once symptomatic
• Prevent by: Gradual osmolality correction, avoid excessive fluid rates
• Early signs: Worsening headache, deteriorating consciousness, new seizures
• If suspected: Hypertonic saline, neurosurgical consultation

Hyperosmolar Hyperglycemic State Complications 1

• Venous thromboembolism prophylaxis mandatory
• Monitor for fluid overload (especially elderly)
• Prevent hypoglycemia and hypokalemia
• Foot care to prevent ulceration

Resolution Criteria and Transition 1

HHS is resolved when ALL of the following are met:

• Osmolality <300 mOsm/kg
• Hypovolaemia corrected (urine output ≥0.5 mL/kg/h)
• Cognitive status returned to baseline
• Blood glucose <15 mmol/L (270 mg/dL)

Transition to subcutaneous insulin:

• Administer basal insulin 2-4 hours BEFORE stopping IV insulin 8
• Calculate dose: 50% of total 24-hour IV insulin requirement 3
• Divide into basal (given once evening) and bolus components (divided by 3 for meals) 3

Disposition and Follow-up

ICU admission is mandatory 3, 9:

• These patients are critically ill with high mortality risk
• Require hourly glucose and electrolyte monitoring initially
• Need continuous assessment for complications

If facial palsy persists after metabolic resolution:

• Ophthalmology referral for eye protection strategies 7
• Neurology consultation for further workup
• Consider delayed corticosteroid therapy for Bell's palsy only after complete metabolic stabilization 6
• Facial plastic surgery referral if no recovery by 3-6 months 7

Key Pitfalls to Avoid

1. Starting insulin before adequate fluid resuscitation - causes dangerous rapid osmolality shifts 1
2. Correcting osmolality too rapidly (>8 mOsm/kg/h) - risks cerebral edema and osmotic demyelination 4, 1
3. Administering corticosteroids for facial palsy during acute HHS - significantly worsens hyperglycemia and increases HHS risk 6
4. Assuming facial palsy is always Bell's palsy - may be reversible metabolic complication requiring only metabolic correction 2
5. Stopping IV insulin without prior subcutaneous insulin - causes rebound hyperglycemia 8

The evidence strongly supports that facial palsy in the context of severe HHS may be a reversible metabolic phenomenon 2, making aggressive metabolic correction the primary therapeutic intervention for both conditions simultaneously.